MAPT and Alzheimer disease: In one study, with a design similar to ours, Bennett and colleagues found that homogenates from AD brain regions with and without amyloid plaques showed increased seeding potential by two- to threefold, using the tau biosensor assay developed by Diamond and also used by us69.